Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Invitae Corporation | NVTA | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0891 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.081 - 1.67 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.0891 | USD |
Invitae Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 25.53M | - | - | - | -0.82 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Invitae News
Date | Time | Source | News Article |
---|---|---|---|
3/06/2024 | 07:31 | Edgar (US Regulatory) | Form 8-K - Current report |
2/06/2024 | 16:07 | Edgar (US Regulatory) | Form 8-K - Current report |
1/30/2024 | 06:00 | PR Newswire (US) | Invitae Partners with BridgeBio Pharma to Harness Genetic.. |
1/29/2024 | 15:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
1/24/2024 | 15:34 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
1/22/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
1/22/2024 | 06:00 | PR Newswire (US) | Invitae Completes Sale of Reproductive Health Assets to.. |
1/18/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
12/21/2023 | 20:20 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
12/21/2023 | 20:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
12/14/2023 | 15:29 | Edgar (US Regulatory) | Form 8-K - Current report |
12/13/2023 | 15:07 | PR Newswire (US) | Invitae Divests Ciitizen Health Data Platform and Implements.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVTA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.4641 | 0.7639 | 0.081 | 0.4675814 | 8,728,758 | -0.375 | -80.80% |
1 Year | 1.39 | 1.67 | 0.081 | 0.8057993 | 9,442,317 | -1.30 | -93.59% |
3 Years | 29.00 | 35.51 | 0.081 | 5.20 | 8,227,783 | -28.91 | -99.69% |
5 Years | 19.40 | 61.59 | 0.081 | 10.74 | 6,011,003 | -19.31 | -99.54% |
Invitae Description
Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. |